Results 191 to 200 of about 895,257 (215)

Provider Role in Transmission of Carbapenem-Resistant Enterobacteriaceae

Infection Control & Hospital Epidemiology, 2017
OBJECTIVEWe sought to evaluate the role healthcare providers play in carbapenem-resistant Enterobacteriaceae (CRE) acquisition among hospitalized patients.DESIGNA 1:4 case-control study with incidence density sampling.SETTINGAcademic healthcare center with regular CRE perirectal screening in high-risk units.PATIENTSWe included case patients with ≥1 ...
Marika E, Grabowski, Hyojung, Kang, Kristen M, Wells, Costi D, Sifri, Amy J, Mathers, Jennifer M, Lobo   +5 more
openaire   +2 more sources

Carbapenem-Resistant Enterobacteriaceae: A Call for Cultural Change

Annals of Internal Medicine, 2014
Starting in 2011, a cluster of infections caused by carbapenem-resistant Enterobacteriaceae (CRE) occurred at the National Institutes of Health Clinical Center.
Tara N, Palmore, David K, Henderson
openaire   +2 more sources

The Emerging Threat From Carbapenem‐Resistant Enterobacteriaceae

Nursing for Women's Health, 2013
The emergence of carbapenem-resistant enterobacteriaceae (CRE) in the United States represents a serious danger to people who are hospitalized and is associated with case mortality rates as high as 50 percent. CRE infections have limited treatment options and the potential to spread widely if prevention and transmission measures are not employed ...
Jessica, Landry, Helen, Hurst
openaire   +2 more sources

Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat

Seminars in Diagnostic Pathology, 2019
The first reports of carbapenem resistance in Enterobacteriaceae isolates occurred in the early 1990s. Researchers published the first report of an isolate that produced Klebsiella pneumoniae carbapenemase in 2001. Since that time, carbapenemase-producing Enterobacteriaceae isolates have disseminated globally.
openaire   +2 more sources

Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: a matched case–control study

Expert Review of Anti-Infective Therapy, 2021
Fahad A S Aleidan, Khalid Alsulaiman
exaly  

Carbapenem-Resistant Enterobacteriaceae

Amália Raiana Fonseca Lobato, Beatriz Lobato da Silva, Artur Silva, Danielle Murici Brasiliense, Rafael Azevedo Baraúna   +4 more
openaire   +1 more source

Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Virulence, 2017
Sandra S Richter, Dror Marchaim
exaly  

Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019

Emerging Microbes and Infections, 2020
Ning Dong, Rong Zhang, Edward Wai-Chi Chan   +2 more
exaly  

Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae

Virulence, 2017
Romney M Humphries, Ritu Banerjee
exaly  

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

Clinical Microbiology and Infection, 2017
Loren G Miller, Bruce Y. Lee, B Y Lee
exaly